Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-07-19 Sale |
2021-07-20 4:12 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
16,700 | $54.57 | $911,245 | 494,546 (Direct) |
View |
2021-07-12 Sale |
2021-07-14 4:50 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $54.9 | $405,527 | 171,589 (Direct) |
View |
2021-06-21 Sale |
2021-06-22 4:26 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
16,700 | $58.59 | $978,480 | 511,246 (Direct) |
View |
2021-06-10 Sale |
2021-06-14 4:08 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $60.88 | $449,697 | 178,976 (Direct) |
View |
2021-05-19 Sale |
2021-05-20 7:52 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
16,700 | $55.71 | $930,276 | 527,946 (Direct) |
View |
2021-05-10 Sale |
2021-05-11 4:16 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $61.97 | $457,772 | 186,363 (Direct) |
View |
2021-04-19 Sale |
2021-04-21 4:14 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
16,700 | $57.63 | $962,433 | 544,646 (Direct) |
View |
2021-04-12 Sale |
2021-04-13 4:05 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $59.43 | $438,978 | 193,750 (Direct) |
View |
2021-03-22 Sale |
2021-03-24 4:05 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President and CEO |
16,700 | $68.49 | $1,143,860 | 640,365 (Direct) |
View |
2021-03-10 Sale |
2021-03-12 9:39 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $74.34 | $549,173 | 201,137 (Direct) |
View |
2020-12-14 Purchase |
2020-12-15 7:07 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
20,000 | $76 | $1,520,000 | 3,156,981 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-07-30 Option Award |
2021-08-03 5:28 pm |
N/A 2031-07-29 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly VP, Finance and CAO |
25,000 | $0 | 25,000 (Direct) |
View |
2021-07-30 Option Award |
2021-08-03 5:22 pm |
N/A 2031-07-29 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2021-07-30 Option Award |
2021-08-03 5:12 pm |
N/A 2031-07-29 |
ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2021-07-30 Option Award |
2021-08-03 5:04 pm |
N/A 2031-07-29 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
225,000 | $0 | 225,000 (Direct) |
View |
2021-06-11 Option Award |
2021-06-15 7:03 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
12,004 | $0 | 12,004 (Direct) |
View |
2021-06-11 Option Award |
2021-06-15 6:59 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Nielsen Jack Director |
12,004 | $0 | 12,004 (Direct) |
View |
2021-06-11 Option Award |
2021-06-15 6:54 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director |
12,004 | $0 | 12,004 (Direct) |
View |
2021-06-11 Option Award |
2021-06-15 6:50 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
12,004 | $0 | 12,004 (Direct) |
View |
2021-06-11 Option Award |
2021-06-15 6:45 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | GOODMAN COREY S Director |
12,004 | $0 | 12,004 (Direct) |
View |
2021-05-03 Option Award(A) |
2021-05-19 5:26 pm |
N/A 2031-05-03 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly VP, Finance and CAO |
125,000 | $0 | 125,000 (Direct) |
View |
2020-05-03 Option Award |
2021-05-05 4:29 pm |
N/A 2030-05-03 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly VP, Finance and CAO |
125,000 | $0 | 125,000 (Direct) |
View |
2021-03-25 Exercise |
2021-03-26 9:39 pm |
N/A 2027-03-30 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
10,000 | $0 | 803,525 (Direct) |
View |
2021-03-25 Exercise |
2021-03-26 9:39 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
10,000 | $0.99 | 803,525 (Direct) |
View |
2021-03-22 Exercise |
2021-03-24 4:05 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President and CEO |
16,700 | $1.91 | 640,365 (Direct) |
View |
2021-03-22 Exercise |
2021-03-24 4:05 pm |
N/A 2029-09-12 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President and CEO |
16,700 | $0 | 640,365 (Direct) |
View |
2021-01-28 Exercise |
2021-01-29 4:15 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer |
6,128 | $4.08 | 255,255 (Direct) |
View |
2021-01-28 Exercise |
2021-01-29 4:15 pm |
N/A 2030-03-09 |
ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer |
6,128 | $0 | 255,255 (Direct) |
View |
2021-01-26 Exercise |
2021-01-28 06:01 am |
N/A 2027-03-30 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
10,000 | $0 | 803,525 (Direct) |
View |
2021-01-26 Exercise |
2021-01-28 06:01 am |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
10,000 | $0.99 | 803,525 (Direct) |
View |